✦ LIBER ✦

Reduced incidence of gastroduodenal ulcers with valdecoxib compared to ibuprofen and diclofenac in patients with osteoarthritis: A multicenter trial

✍ Scribed by Goldstein, Jay L.; Fakouhi, Kaffa M.; Zhao, William W.; Verburg, Kenneth M.; Kent, Jeffrey D.; Recker, David P.; Hubbard, Richard C.

Book ID: 124104845
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 158 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)82969-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced incidence of gastroduodenal ulce

Reduced incidence of gastroduodenal ulcers with valdecoxib compared to diclofenac in patients with rheumatoid arthritis: a multicenter trial

✍ Jay L. Goldstein; Jeffery D. Kent; William W. Zhao; David Recker; Kenneth M. Ver 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 29 KB

Reduced incidence of gastroduodenal ulce

Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

✍ A. J. Kivitz; S. Nayiager; T. Schimansky; A. Gimona; H. J. Thurston; C. Hawkey 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Reduced incidence of gastroduodenal ulce

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

✍ J.L Goldstein; P Correa; W.W Zhao; A.M Burr; R.C Hubbard; K.M Verburg; G.S Geis 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 466 KB

Incidence of gastroduodenal ulcers durin

Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis

✍ Raymond CHEUNG; Tien-Tsai CHENG; Yi DONG; Hsiao-Yi LIN; Kamchuen LAI; Chak-sing 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 224 KB

A multicenter, randomized, controlled tr

A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis

✍ Truitt, K. E.; Sperling, R. S.; Ettinger, W. H.; Greenwald, M.; DeTora, L.; Zeng 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views